Daria B. Crittenden

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi et al. · New England Journal of Medicine · 2016 · 1.6K citations · Full text

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Bente Langdahl, Cesar Libanati, Daria B. Crittenden et al. · The Lancet · 2017 · 450 citations

Bone Disease, Sclerostin, Bone Health +7

Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout

Daria B. Crittenden, Robert A. Lehmann, LAURA SCHNECK et al. · The Journal of Rheumatology · 2012 · 219 citations · Full text

Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

Robert T. Keenan, William R. O’Brien, Kristen H. Lee et al. · The American Journal of Medicine · 2011 · 196 citations

Urology, Gouty Arthritis, Therapeutic Controversy +4

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

Gideon M. Hirschfield, Christopher L. Bowlus, Marlyn J. Mayo et al. · New England Journal of Medicine · 2024 · 192 citations